Prelude Therapeutics to collaborate with BeiGene to evaluate PRT2527 + zanubrutinib in hematologic cancers

Jorge Cortes named editor-in-chief of Blood Global Hematology

Jorge Cortes, director of the Georgia Cancer Center at Augusta University, was selected as the inaugural editor-in-chief of the newest addition to the Blood journals portfolio: Blood Global Hematology.

April 19, 2024

Vol.50 No.16

In Brief

University of Cincinnati opens blood cancer healing center

The University of Cincinnati Cancer Center has opened the Blood Cancer Healing Center, a facility that aims to advance research, treatment, and wellness for blood cancer patients.

February 16, 2024

Vol.50 No.07

In Brief

36 early-career investigators receive ASH 2024 Scholar Award

Thirty six early-career investigators received the the American Society of Hematology 2024 Scholar Awards.

February 02, 2024

Vol.50 No.05

In Brief

Mohandas Narla begins term as 2024 ASH president

Mohandas Narla, head of the laboratory of red cell physiology at New York Blood Center Enterprises, began his term as president of the American Society of Hematology. He will serve a year-long term through December 2024.

January 12, 2024

Vol.50 No.02

In Brief

David Swoboda named clinical director of Leukemia Program at TGH Cancer Institute

David Swoboda was named clinical director of leukemia at Tampa General Hospital Cancer Institute.

January 05, 2024

Vol.50 No.01

Clinical

After revolutionizing treatment of blood cancers, imatinib stands poised to eradicate malaria

Imatinib—the pathbreaking cancer drug that gave Philadelphia chromosome-positive chronic myeloid leukemia patients near-normal life expectancies—now stands poised to save even more lives.

November 03, 2023

Vol.49 No.41

By Jacquelyn Cobb